Healthcare -
Biotechnology - NASDAQ - US
$ 0.6625
-2.17 %
$ 51.8 M
Market Cap
4.14
P/E
CTMX - PRE-TAX INCOME
Pre-tax Income CTMX - CytomX Therapeutics, Inc.
3.32 M
LAST VALUE
42.82%
2 YEAR CAGR
15.41%
5 YEAR CAGR
8.30%
10 YEAR CAGR